Dr Lal PathLabs Q2: Company declares 2nd interim dividend, bonus share in 1:1 ratio; check all details

Dividend

In its earnings release, Dr Lal PathLabs said the company's board has approved the declaration of the second interim dividend of ₹7 per equity share (at 70% on a face value of ₹10 each) for the financial year 2025-26. The record date for the purpose of payment of the interim dividend shall be November 7, 2025. The second interim dividend will be dispatched/credited within 30 days of its declaration.

Bonus Issue

The board also approved the issuance of bonus equity shares in the proportion of 1:1, i.e., one fully paid-up equity share of face value of ₹10 each for every one fully paid-up equity share of face value of ₹10 each held by the members of the company as on the record date, subject to members', statutory, and regulatory approvals, as applicable.

The record date for determining the entitlement of the members of the company to receive bonus equity shares will be announced in due course.

Shares of the company after the results announcement were trading over 2% higher at ₹3,153.90 apiece on the NSE.

Dr Lal PathLabs Q2: Key numbers

The company reported revenue from operations on a consolidated basis at ₹731 crore, up 11% against ₹660 crore logged in the year-ago period. Its net profit rose 17% YoY to ₹151 crore from ₹129 crore registered in the corresponding quarter of the previous fiscal year. Its operating profit, or EBITDA, grew 11% YoY to ₹224.3 crore against ₹202 crore.